Clinical-correlative analysis of patients at risk of schizophrenia

   Objective: Establishing a link between the structure and severity of psychopathological symptoms and the level of functioning in patients at risk of schizophrenia.

   Material and Methods: The study examined 38 patients with a depressive episode with attenuated positive symptoms (APS) from the risk group of schizophrenia hospitalized in 2011-2015. The follow-up was 7.3 ± 1.7 years. At the time of the examination, all patients were in remission. HDRS (Hamilton Depression Rating Scale), SOPS (Scale of Prodromal Symptoms) and (SANS) Scale for Assessment of Negative Symptoms were used. Statistical analysis was carried out using the Statistica 12 program.
   Results: At the time of the survey, 21.1% of the cases were diagnosed as schizophrenic (F25 and F20 according to ICD-10), 28.9 % as affective (F34.0, F31.3, F31.7 and F33.4), 13.2 % as personal disorders (F60.1, F60.a, F3.8 per cent) and 36,8 % as schizotypal disorders (F21.3, F21.4, F21.5, F21.8). Social performance on the PSP scale of 13.2 % was rated as high (100-81 points), 28.9 % and 31.6 % as average (80-61 and 60-41 points respectively) and 26.3 % as low (less than 40 points). The strongest correlations (p˂0.05) are found between total scores on the SOPS scale, negative SOPS scores, total SANS score and PSP score (- 0.854, - 0.876, - 0.812 respectively), subscale of negative SOPS symptoms and socially beneficial PSP activity (-0.831) subscale of apathy-anhedonia SANS and social relations PSP (0,801).

   Discussion: A high level of social functioning is possible provided there is a complete reduction of the prodromal and depressive symptoms, at medium levels, functioning is determined primarily by increasing negative symptoms, especially the domain of avolition - apathy, and low levels are formed by persistent APS, increasing symptoms of disorganization and negative symptoms.

   Conclusion: The study showed that the outcome of the first depressive episode with the risk symptoms of schizophrenia is generally characterized by some degree of decline in social functioning, which cannot be considered as a phenomenon in its own right, on the contrary, it’s a derivative of psychopathological symptoms.

1. Omelchenko M. A. Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum. Psihiatriya. 2021; 19 (1): 16-25. (In Russ.). doi: 10.30629/2618-6667-2021-19-1-16-25

2. Andreasen N. C. Review the Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl. 1989; 7: 49–58. doi: 10.1192/S0007125000291496

3. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960; 23: 56–62. doi: 10.1136/jnnp.23.1.56

4. Lemos-Giráldez S., Vallina-Fernández O., Fernández-Iglesias P., Vallejo-Seco G., Fonseca-Pedrero E., Paíno-Piñeiro M., Sierra-Baigrie S., García-Pelayo P., Pedrejón-Molino C., Alonso-Bada S., Gutiérrez-Pérez A., Ortega-Ferrández J. A. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res. 2009; 115 (2-3): 121-9. doi: 10.1016/j.schres.2009.09.011. Epub 2009 Sep 27. PMID: 19786339.

5. Lewandowski K. E. Neuroprogression across the Early Course of Psychosis. J. Psychiatr. Brain Sci. 2020; 5: e200002. doi: 10.20900/jpbs.20200002

6. Lin A. Outcomes of nontransitioned cases in a sample at ultra‐high risk for psychosis. Am. J. Psychiatry. 2015; 172: 249–258. doi: 10.1176/appi.ajp.2014.13030418

7. Malla A. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. World Psychiatry.2017; 16 (3): 278–286. doi: 10.1002/wps.20456

8. Marín O. Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med. 2016; 22 (11): 1229–1238. doi: 10.1038/nm.4225

9. McGorry P. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World Psychiatry. 2018; 17 (2): 133–142. doi: 10.1002/wps.20514

10. Miller T. J. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity.Am. J. Psychiatry. 2002; 159: 863–865. doi: 10.1176/appi.ajp.159.5.863

11. Miller T. J. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999 (70): 273–287. doi: 10.1023/A:1022034115078

12. Polari A. Clinical trajectories in the ultra‐high risk for psychosis population. Schizophr. Res. 2018; 197: 550–556. doi: 10.1016/j.schres.2018.01.022

13. Rutigliano G. Persistence or recurrence of non‐psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J Affect. Disord. 2016; 203: 101–110. doi: 10.1016/j.jad.2016.05.053

14. Schlosser D. A., Jacobson S., Chen Q., Sugar C. A., Niendam T. A., Li G., Bearden C. E., Cannon T. D. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012; 38 (6): 1225-33. doi: 10.1093/schbul/sbr098.